🇺🇸 FDA
Pipeline program

Within-Subject test of blinded study medication

IRB00160629

Phase 2 small_molecule completed

Quick answer

Within-Subject test of blinded study medication for Low Back Pain, Recurrent is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Low Back Pain, Recurrent
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials